Design Therapeutics DSGN
NASDAQ DSGN
$10.73 -0.37 (-3.33%)
At close: Oct 21, 2026 · 4:00 PM EDT

Design Therapeutics (DSGN) Total Non-Current Liabilities (2020 - 2021)

Updated

Design Therapeutics (DSGN) reported Total Non-Current Liabilities of $8.78 million for Q3 2021, up 157.8% from the prior quarter.

Analysis

Design Therapeutics (DSGN) Total Non-Current Liabilities (2020 - 2021) Analysis & Trends

At the end of FY2020, Design Therapeutics posted Total Non-Current Liabilities of $47.69 million.

  • Five-year quarterly Total Non-Current Liabilities spans a low of $3.41 million in Q2 2021 and a high of $47.69 million in Q4 2020.
  • Per Business Quant data, the three quarters before Q3 2021 came in at $3.41 million (Q2 2021), $3.71 million (Q1 2021) and $47.69 million (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 106.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 97.04 Bn
10 Design Therapeutics 669.43 Mn -186.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 8.78 Mn
Jun 30, 2021 3.41 Mn
Mar 31, 2021 3.71 Mn
Dec 31, 2020 47.69 Mn
API Access

Design Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=DSGN&period=max&api_key=YOUR_API_KEY